SBIR/STTR Research Award
CRYOPRESERVATION OF TRANSGENIC EMBRYOS
Award amount
$47,800Program and phase
SBIR · Phase IAward year
1990Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Transgenic Sciences Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
TRANSGENIC MOUSE TECHNOLOGY PROVIDES A POWERFUL BIOLOGICAL ASSAY FOR STUDYING ONCOGENE EXPRESSION AND ACTIVITY IN WHOLE TISSUE AND ORGAN DEVELOPMENT. EMBRYO VITRIFICATION TECHNOLOGY ALLOWS RESEARCHERS TO STORE TRANSGENIC MOUSE EMBRYOS FOR FUTURE STUDIES AND DISTRIBUTION, ENABLING MORE RESEARCHERS TO USE THESE IMPORTANT EXPERIMENTAL ANIMALS. CRYOPRESERVATION OF EMBRYOS USING VITRIFICATION TECHNOLOGY OFFERS MANY ADVANTAGES OVER CONVENTIONAL EMBRYO-FREEZING TECHNIQUES. VITRIFICATION IS FAST, EASY, AND INEXPENSIVE. RECENT IN VITRO DEVELOPMENT STUDIES INDICATE THAT A HIGH PERCENTAGE OF VITRIFIED EMBRYOS WILL SURVIVE THIS LOW-TEMPERATURE STORAGE PROCEDURE. HOWEVER, IN VIVO DEVELOPMENT OF VITRIFIED EMBRYOS HAS BEEN INCONSISTENT. THIS PHASE I RESEARCH WILL DETERMINE WHETHER VITRIFIED EMBRYOS FROM THREE DIFFERENT EMBRYONIC DEVELOPMENTAL STAGES OBTAINED FROM TWO DIFFERENT STRAINS OF MICE WILL DIFFER IN THEIR IN VIVO DEVELOPMENT. THE TYPE OF VITRIFIED EMBRYO THAT MOST CONSISTENTLY DEVELOPS TO OFFSPRING AT A HIGH RATE WILL BE USED IN PHASE II TO STORE SEVERAL LINES OF TRANSGENIC MICE IMPORTANT FOR CANCER RESEARCH.
Technology keywords
Not reported